Resultados de búsqueda - "chemotherapy"

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers por Van Roosbroeck, Katrien, Fanini, Francesca, Setoyama, Tetsuro, Ivan, Cristina, Rodríguez Aguayo, Cristian, Fuentes Mattei, Enrique, Xiao, Lianchun, Vannini, Ivan, Redis, Roxana S., D'Abundo, Lucilla, Zhang, Xinna, Nicoloso, Milena S., Rossi, Simona, González Villasana, Vianey, Rupaimoole, Rajesha, Ferracin, Manuela, Morabito, Fortunato, Neri, Antonino, Ruvolo, Peter P., Ruvolo, Vivian R., Pecot, Chad V., Amadori, Dino, Abruzzo, Lynne V., Calin, Steliana, Wang, Xuemei, You, M. James, Ferrajoli, Alessandra, Orlowski, Robert, Plunkett, William, Lichtenberg, Tara M., Davuluri, Ramana V., Berindan Neagoe, Ioana, Negrini, Massimo, Wistuba, Ignacio I., Kantarjian, Hagop M., Sood, Anil K., Lopez Berestein, Gabriel, Keating, Michael J., Fabbri, L. Muller, Calin, George A.

“…Conclusions: Our findings support the existence of an miR155/TP53 feedback loop, which is involved in resistance to chemotherapy and which can be specifically targeted to overcomedrugresistance,animportantcauseofcancer-relateddeath. …”
Enlace del recurso

Study of the effect of IMMUNEPOTENT CRP in combination with chemotherapies on cancer cells and immune system cells por Rivera Lazarín, Ana Luisa

Enlace del recurso

Study of the effect of IMMUNEPOTENT CRP in combination with chemotherapies on cancer cells and immune system cells por Rivera Lazarín, Ana Luisa

Enlace del recurso

Real-world practice of acute leukemia intrathecal chemotherapy administration: a mexican nationwide survey por Colunga Pedraza, Julia Esther, Colunga Pedraza, Perla Rocío, Benavides López, Hilda Valeria, Mares Gil, José Eduardo, Jiménez Antolínez, Yajaira Valentine, Mancías Guerra, Consuelo, Velasco Ruiz, Ileana Yazmín, González Llano, Óscar

“…Introduction: Intrathecal chemotherapy is a mainstay component of acute lymphoblastic leukemia treatment. …”
Enlace del recurso

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron por Aapro, Matti, Karthaus, Meinolf, Schwartzberg, Lee, Bondarenko, Igor, Sarosiek, Tomasz, Oprean, Cristina, Cardona Huerta, Servando, Hansen, Vincent, Rossi, Giorgia, Rizzi, Giada, Borroni, Maria Elisa, Rugo, Hope

“…NEPA showed superior prevention of chemotherapy-induced nausea and vomiting (CINV) compared with oral PALO in a single chemotherapy cycle; maintenance of efficacy/safety over continuing cycles is the objective of this study. …”
Enlace del recurso

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron por Aapro, Matti, Karthaus, Meinolf, Schwartzberg, Lee, Bondarenko, Igor, Sarosiek, Tomasz, Oprean, Cristina, Cardona Huerta, Servando, Hansen, Vincent, Rossi, Giorgia, Rizzi, Giada, Borroni, Maria Elisa, Rugo, Hope

“…NEPA showed superior prevention of chemotherapy-inducednauseaandvomiting(CINV)compared with oral PALO in a single chemotherapy cycle; maintenance of efficacy/safetyover continuingcycles is the objectiveof this study. …”
Enlace del recurso

Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer por Castro Rojas, Carlos Andrés, Esparza Mota, Antonio R., Hernández Cabrera, Francisco, Romero Díaz, Víktor J., González Guerrero, Juan Francisco, Maldonado Garza, Héctor Jesús, García González, Irma S., Buenaventura Cisneros, Sergio, Sanchez Lopez, Josefina Y., Ortiz López, Rocío, Camacho Morales, Alberto, Barboza Quintana, Oralia, Rojas Martínez, Augusto

“…Abstract Background: Fluoropyrimidines form the chemotherapy backbone of advanced and metastatic colorectal cancer (CRC). …”
Enlace del recurso

Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP por Rivera Lazarín, Ana Luisa, Calvillo Rodríguez, Kenny Misael, Izaguirre Rodríguez, Mizael, Vázquez Guillén, José Manuel, Martínez Torres, Ana Carolina, Rodríguez Padilla, Cristina

Enlace del recurso

The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth por Rodríguez Salazar, María del Carmen, Franco Molina, Moisés Armides, Mendoza Gamboa, Edgar, Martínez Torres, Ana Carolina, Zapata Benavides, Pablo, López González, Jose Sullivan, Coronado Cerda, Erika Evangelina, Alcocer González, Juan Manuel, Tamez Guerra, Reyes Silvestre, Rodríguez Padilla, Cristina

Enlace del recurso

Pedicle screw sublaminary wiring (PSSW) combined with anti-tuberculosis chemotherapy for treating spinal tuberculosis in adults: A cohort study por Azharuddin, Abdul, Fajar, J. K.

Enlace del recurso

IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model por Santana Krimskaya, Silvia Elena, Franco Molina, Moisés Armides, Zárate Triviño, Diana Ginette, Prado García, Heriberto, Zapata Benavides, Pablo, Torres del Muro, Felipe, Rodríguez Padilla, Cristina

Enlace del recurso

PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): phallcon study por Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, Hagop M., Gómez Almaguer, David, Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J. M.

Enlace del recurso

Metastatic triple-negative breast cancer successfully treated with bicalutamide por Salazar Mejía, Carlos Eduardo, García Gutierrez, María Elena, Rodríguez Alvarez, Carlos Javier, Flores Caballero, Miguel Angel, Wimer Castillo, Blanca Otilia, Vidal Gutiérrez, Oscar

“…The current treatment of metastatic TNBC is traditionally limited to chemotherapy. Androgenic receptors (AR) are an emerging target with therapeutic potential in TNBC refractory to chemotherapy. …”
Enlace del recurso

Farmacogenética de la quimioterapia de los tumores gastrointestinales. por Castro Rojas, Carlos Andrés

“…In a prospective analysis of patients with gastrointestinal tumors, we found an association of alleles 3R(rs45445694) and G (rs2853542) with a worse response to chemotherapy (OR=4.684, p=0.004). The presence of the 6bp+/6bp+ genotype in the 3’UTR variant (rs151264360) was associated with a better response to chemotherapy (OR=4.176, p=0.004). …”
Enlace del recurso

Farmacogenética de la quimioterapia de los tumores gastrointestinales. por Castro Rojas, Carlos Andrés

“…In a prospective analysis of patients with gastrointestinal tumors, we found an association of alleles 3R(rs45445694) and G (rs2853542) with a worse response to chemotherapy (OR=4.684, p=0.004). The presence of the 6bp+/6bp+ genotype in the 3’UTR variant (rs151264360) was associated with a better response to chemotherapy (OR=4.176, p=0.004). …”
Enlace del recurso

The effect of hypnotherapy on the quality of life in women with breast cancer por Téllez López, Arnoldo, Juárez García, Dehisy Marisol, Jaime Bernal, Leticia, Medina de la Garza, Carlos Eduardo, Sánchez, Teresa J.

“…Cancer is a chronic disease that significantly affects the quality of life of patients who suffer from it, because they must face stressful situations, including their diagnosis, surgical procedures, and the adverse effects of chemotherapy and radiotherapy. Objective. To evaluate the effects of hypnotherapy on breast cancer patients’ quality of life during chemotherapy. …”
Enlace del recurso

Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro por Garza Morales, Rodolfo, González Ramos, Roxana, Chiba, Akiko, Montes de Oca Luna, Roberto, McNally, Lacey R., McMasters, Kelly M., Gomez Gutierrez, Jorge G

“…Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer, and treatment is limited to chemotherapy and radiation. Oncolytic virotherapy may be a promising approach to treat TNBC. …”
Enlace del recurso

In vitro activity of a new isothiazoloquinolone, ACH-702, against mycobacterium tuberculosis and other mycobacteria por Molina Torres, Carmen Amelia, Ocampo Candiani, Jorge, Rendón, Adrian, Pucci, Michael J., Vera-Cabrera, Lucio

Enlace del recurso

1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma por Rodríguez Gutiérrez, René, Zapata Rivera, María Azucena, Quintanilla Flores, Dania Lizet, Camara Lemarroy, Carlos Rodrigo, Lavalle González, Fernando Javier, González González, José Gerardo, Villarreal Pérez, Jesús Zacarías

“…After the first cycle of chemotherapy with bleomycin, etoposide and cisplatin, normocalcemia was restored. …”
Enlace del recurso

Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis por Martin Vicente, Adela, Guarro, Josep, González González, Gloria María, Lass Flörl, Cornelia, Lackner, Michaela, Capilla, Javier

Enlace del recurso